Somaiya Mayur Ian
- SEC CIK
- 0001760303
In the past year, 2 open-market sale filings worth $3.43M and no purchases.
Current role at each company
- NAMS NewAmsterdam Pharma Co N.V.Chief Financial Officeras of Jan 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.43M
- 2 filings
- Net
- −$3.43M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Somaiya Mayur Ian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2026 (view filing) | Jan 20-21 | 2 days | Somaiya Mayur IanChief Financial Officer | SSale | −100.0K | $32.61 | −$3.26M | −63.1%58.4K after | 5 lots10b5-1 |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Somaiya Mayur IanChief Financial Officer | SSale | −5.12K | $33.25 | −$170.2K | −13.5%32.9K after | 10b5-1 |
| Jan 29, 2025 (view filing) | Jan 27-28 | 2 days | Somaiya Mayur IanChief Financial Officer | SSale | −61.9K | – | – | −62.0%38.0K after | 4 lots10b5-1 |